Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Merseburger

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Prostate Cancer and Prostatic Diseases|September 10, 2004
Comparison of external radiation therapy vs radical prostatectomy in lymph node positive prostate cancer patientsR Kuefer, B G Volkmer, M Loeffler, et al.
Der Urologe. Ausg. A|August 16, 2014
[Visual diagnosis while performing transurethral resection of bladder tumors: power or myth?]S Steffens, A J Schrader, R Lehmann, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2005
Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levelsM Horstmann, A S Merseburger, E von der Heyde, et al.
ESMO Open|May 13, 2021
SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapyA Bamias, A S Merseburger, Y Loriot, et al.
Der Urologe. Ausg. A|August 19, 2007
[The interdisciplinary approach to improve treatment quality of prostate cancer. Optimized nerve sparing in radical prostatectomy]K-D Sievert, A G Anastasiadis, J Hennenlotter, et al.
Neuropathology and Applied Neurobiology|May 12, 2007
De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survivalM Mittelbronn, D Capper, B Bunz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2021
Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trialA Jayaram, A Wingate, D Wetterskog, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2023
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancerS Chowdhury, A Bjartell, N Agarwal, et al.
World Journal of Urology|December 18, 2012
The use of mannitol in partial and live donor nephrectomy: an international surveyM Cosentino, A Breda, F Sanguedolce, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Prostate Cancer and Prostatic Diseases|September 10, 2004
Comparison of external radiation therapy vs radical prostatectomy in lymph node positive prostate cancer patientsR Kuefer, B G Volkmer, M Loeffler, et al.
Der Urologe. Ausg. A|August 16, 2014
[Visual diagnosis while performing transurethral resection of bladder tumors: power or myth?]S Steffens, A J Schrader, R Lehmann, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2005
Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levelsM Horstmann, A S Merseburger, E von der Heyde, et al.
ESMO Open|May 13, 2021
SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapyA Bamias, A S Merseburger, Y Loriot, et al.
Der Urologe. Ausg. A|August 19, 2007
[The interdisciplinary approach to improve treatment quality of prostate cancer. Optimized nerve sparing in radical prostatectomy]K-D Sievert, A G Anastasiadis, J Hennenlotter, et al.
Neuropathology and Applied Neurobiology|May 12, 2007
De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survivalM Mittelbronn, D Capper, B Bunz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2021
Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trialA Jayaram, A Wingate, D Wetterskog, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2023
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancerS Chowdhury, A Bjartell, N Agarwal, et al.
World Journal of Urology|December 18, 2012
The use of mannitol in partial and live donor nephrectomy: an international surveyM Cosentino, A Breda, F Sanguedolce, et al.
Pageof 8